Speakers
Tim Wilton
Andrew Porteous
Chris Boulton
Jonathan Evans
Professor Andrew Price
Professor Mark Wilkinson
Olivia O’Malley
Alexander Matthews
Patricia Navvuga
Rebecca Beesley
External Organisation
We will be providing an interactive update of the work of the NJR as it relates to changes and progress in how we capture and present data, including updates on NJR research projects and the opportunity for the discussion of practical clinical cases and how the NJR handles them.
Chair: Tim Wilton & Andrew Porteous
Agenda:
08:30 - 08:35 Andrew Porteous, NJR Editorial Committee
Welcome and Launch of the NJR Annual Report 2026
08:35 - 08:40 Tim Wilton, NJR Medical Director & Chris Boulton, Director of Operations, NJR
What's New in the NJR?
08:40 - 08:45 Jonathan Evans, Clinical Senior Lecturer in Trauma and Orthopaedics, University of Exeter
The Effect of Cement on Outcome
08:45 - 08:50 Professor Andrew Price, Consultant Knee Surgeon, Oxford University Hospitals
PROMs: Why and Which Ones?
08:50 - 08:55 Andrew Porteous, Consultant Specialist Knee Surgeon, Avon Orthopaedic Centre(AOC), Bristol
Clinical Case: Challenges in Recording What We Do
08:55 - 09:20 Delegate Q&A
Section 1 Presentations
09:20 - 09:24 Professor Mark Wilkinson
Introduction to the NJR Supported Research Session
09:24 - 09:31 Alexander Matthews, GIRFT
Higher Surgeon Volume Reduces Early Failure in First-Time Revision of Non-Infected Total Knee Arthroplasty
09:31 - 09:38 Patricia Navvuga, University of Bristol
Costs and Outcomes After Primary and Revision Hip Replacements by Implant Bearing Materials
09:38 - 09:45 Timothy Fowler, University of Bristol
Association Between Surgeon Training Grade and the Risk of Revision Following Total Knee Replacement
09:45 - 09:52 Olivia O'Malley, Imperial College London
Reverse Shoulder Arthroplasty for Acute Trauma vs Trauma Sequelae Following Failed Conservative Management
09:52 - 09:56 Rebecca Beesley, NJR Board Patient Representative & Co-Chair, NJR Patient Network
The Patient Network – How the Patient Voice Is Embedded in the National Joint Registry
09:56 - 09:59 Professor Sir Paul Curran, NJR Chair
The NJR – Looking Ahead
09:59 - 10:00 Tim Wilton, NJR Medical Director
Closing Remarks
Tim Wilton trained at Oxford and at UCH medical school and in Orthopaedics at Nottingham, Harlow Wood, Derby and South Wales with travelling fellowships in N America, Strasbourg, Bern and Ljubljana. He has an entirely elective practice in lower limb arthroplasty and has specialised in knee replacement and knee revision surgery for the last 30 years. He has a lifetime personal experience of over 2500 hip and 3500 knee replacements.
Tim teaches widely on technical aspects of knee replacement and has been invited lecturer throughout the world and at the major European, North American and International Knee Surgery organisations.
Tim has been President of the BOA and of BASK, and Chairman of the Bone and Joint Journal.
He is NJR Medical Director and Vice Chair, NJR Board.
Andrew has been a Consultant Specialist Knee Surgeon at the Avon Orthopaedic Centre(AOC) in Bristol, UK for over 23 years. He holds a number of roles within the National Joint Registry including: Chair of the Editorial Committee, Vice-chair of the Surgical Performance Committee, Member of the NJR Board and the Executive Committee.
Andrew is a Past President of the British Assoc for Surgery of the Knee (BASK) and served on the BASK Executive Committee for 12 years. He has previously been the Clinical Lead for Knee Surgery at the AOC for over 15 years, and the Lead for Elective Orthopaedics for five years. He is on the steering committee for the NHSE/GIRFT Revision Knee Network project and is a co-author of National Guidelines for treatment of ACL injuries and Revision knee replacement.
Andrew’s research interests include: Partial, total & revision knee arthroplasty, implant retrieval analysis, infection & knee injury. He has been involved in the development and ongoing work of ODEP and Beyond Compliance for Knees. He is a Member of the BASK, BOA, EKS, ESSKA, EKA and ISAKOS; he holds a Master’s Degree in Orthopaedic Engineering.
Chris Boulton, NJR Director of Operations, leads the strategic and operational work of the registry and has worked for the NJR in senior roles for the past eight years.
With more than 20 years’ experience in clinical audit, Chris has extensive experience in health data, analytics, and operational leadership roles. He has particular expertise in delivering complex national programmes in orthopaedics, improving data quality, and translating insight into meaningful impact across the health system.
Jonathan Evans is a Clinical Senior Lecturer in Trauma & Orthopaedics at the University of Exeter and Consultant hip surgeon at the Exeter Hip Unit. Having completed his doctorate at the University of Bristol, he now works on the data analysis team of the National Joint Registry (NJR). His research interests include Post-operative Periprosthetic Femoral Fractures (POPFF) and he is currently developing a Core Outcome Set for POPFF in preparation for trials in this area. He is working towards securing funding for an international collaborative RCT investigating the management of Prosthetic Joint Infection (PJI), the ROADMAP trial. He is also working to develop methods to assess the environmental impact of health technologies and embed this within both trials and observational research such as the NJR.
Professor Andrew Price studied medicine at the University of Cambridge (Gonville and Caius College) before completing his clinical studies at St.Thomas' Hospital in London. For his Orthopaedic training he joined the Oxford training programme in 1997, becoming a Clinical Lecturer in NDORMS in 2001.
He was awarded a DPhil in 2003 through the University of Oxford (Worcester College), studying the Oxford partial knee replacement. He then completed a year of specialist Knee Fellowship training in Melbourne, returning to NDORMs and the Nuffield Orthopaedic Centre in 2004, where he was subsequently appointed Reader and Honorary Consultant in Knee Surgery.
In 2011, through the University of Oxford Recognition of Distinction exercise, he was made a Professor of Orthopaedic Surgery at NDORMS. His clinical work as a Consultant Knee Surgeon is based at the Nuffield Orthopaedic Centre, where he has recently been appointed to Clinical Director T&O. His research is based in NDORMS at the Botnar Centre, where he Leads the Knee Research Group.
Andrew is Fellow of Worcester College (Tutor for Graduate Entry Medical Studies), a member of the British Orthopaedic Association, member of the UK National Joint Registry Steering Committee and Past President of the British Association for Surgery of the Knee (BASK)
Professor Wilkinson's principal research interests are in the genetic and metabolic aspects of joint replacement, osteoarthritis, and other associated diseases. Professor Wilkinson is a key clinical collaborator in the Genetics of Osteoarthritis initiative. He and his collaborators have been instrumental in determining our current understanding of the genetic architecture of osteoarthritis. He conducted the first genome-wide scan into hip dysplasia, and into osteolysis and heterotopic ossification after hip replacement, He published the first study in humans to show that bisphosphonates may suppress bone loss after hip replacement and the first clinical trial to show that the human monoclonal antibody denosumab can inhibit osteolysis lesion activity. Other areas of research include exploration of the molecular mechanisms that underpin osteoarthritis development and identifying potential novel pharmacological strategies for its treatment. He has worked on the genetics of osteoarthritis has uncovered novel gene associations with severity and pattern of hip and knee OA, bone remodelling responses to disease, and hip shape. He also studied the systemic health effects of metal ion exposure after hip resurfacing has demonstrated effects on bone cells, cardiovascular, and other systems.
Professor Wilkinson’s principal funding sources are Versus Arthritis, NIHR, Wellcome, MRC, Royal College of Surgeons of England, Cavendish Foundation, John Charnley Trust and industry.
Miss Olivia O’Malley is a Trauma & Orthopaedic Registrar in the North West Thames Deanery and is in the final year of her PhD at Imperial College London. She is a former Royal College of Surgeons of England Research Fellow, with a clinical and academic interest in shoulder and elbow surgery.
Her PhD research focuses on the increasing use of reverse shoulder arthroplasty (RSA) in the UK, with much of her work using linked National Joint Registry data to evaluate contemporary practice and outcomes. Her research has explored changing indications for RSA, outcomes and revision surgery, as well as surgeon decision-making when choosing between arthroplasty options. Through this work, she has developed a particular interest in the use of national registry data to understand real-world surgical practice, evaluate outcomes and inform clinical decision-making.
Rebecca Beesley is a Patient Representative on the NJR Board and also co-Chair of the NJR Patient Network. She brings her own lived experience into the work of the NJR, having been a patient who has undergone hip replacement surgery.
Having had Juvenile Idiopathic Arthritis (JIA) for most of her life, Rebecca co-founded the charity ‘Juvenile Arthritis Research’, which supports many families affected by the condition, where she is the lead on family support and communications. She is passionate about patient involvement and has been involved in projects including the JIA Learn quality improvement project - a British Society for Rheumatology (BSR) and Getting it Right First Time (GIRFT) funded project - and the BSR’s Pain in Inflammatory Arthritis Guideline working group. She has delivered over 20 publications and conference presentations to date.
Rebecca has a background in Financial Services and Market Research having graduated from the University of Bath with a 1st Class honours degree in Business Administration.
Professor Sir Paul Curran
Sir Paul was appointed Chair of the National Joint Registry in May 2022. President of City, University of London from 2010 to 2021, he served previously as Vice-Chancellor of Bournemouth University and Deputy Vice-Chancellor of the University of Southampton. A former academic at the Universities of Sheffield, Reading and Swansea, a NASA research scientist at Ames California and advisor to the European Space Agency, his research on environmental Earth observation has focused on climate change.
He is Chair of the Multiple Sclerosis Society, a Director of the Universities Superannuation Scheme and President of the Remote Sensing & Photogrammetry Society. He was Chair of the national Review Body on Doctors’ & Dentists’ Remuneration, Universities & Colleges Employers Association and The Conversation UK and was also a Member of the Natural Environment Research Council, Quality Assurance Agency, London Higher and Universities UK.
Sir Paul holds the degrees of BSc (Sheffield), MBA (Southampton), PhD and DSc (Bristol), Honorary DSc (Grand École ESCP, Paris & Peter the Great University, St Petersburg) and was Knighted in the 2016 New Year Honours for ‘services to higher education’.